Polymerase Chain Reaction Market Driven by Rising Infectious Disease Testing

The global Polymerase Chain Reaction (PCR) market continues to play a pivotal role in the evolution of molecular diagnostics and life sciences. PCR is a foundational technology that enables the rapid and precise amplification of DNA and RNA, making it indispensable for applications ranging from infectious disease detection and oncology to genetic testing, forensic science, and advanced research. As healthcare systems worldwide increasingly emphasize early diagnosis, accuracy, and personalized treatment strategies, PCR remains at the core of modern diagnostic workflows. The global PCR market size is estimated to grow from US$26.9 billion in 2026 to US$31.3 billion by 2033, expanding at a compound annual growth rate (CAGR) of 2.2% during the forecast period from 2026 to 2033.